Titan Medical Inc. Retains New York-Based Bertner Advisors, LLC for Investor Relations Services
June 17 2014 - 8:47AM
Marketwired
Titan Medical Inc. Retains New York-Based Bertner Advisors, LLC for
Investor Relations Services
TORONTO, ONTARIO--(Marketwired - Jun 17, 2014) - Titan Medical
Inc. ("Titan" or the "Company") (TSX-VENTURE:TMD)(OTCQX:TITXF)
announced today that it has retained Bertner Advisors, LLC as its
investor relations advisor. Services to be provided in the United
States to Titan by Bertner Advisors include counsel on investor
relations strategy.
Headquartered in New York City, Bertner Advisors is a financial
communications consulting firm providing strategic investor
relations services to health care companies. The Titan Client
Management Team providing these services includes Monique Kosse,
Managing Director, and Lena Adams, Associate Director. Bertner
Advisors, LLC is privately held and solely owned by Sherry L.
Bertner, who founded the firm in 2013.
Sherry Bertner, Chief Executive Officer of Bertner Advisors,
commented, "Our team is thrilled to partner with Titan Medical. We
look forward to working with management to design and execute an
investor relations strategy that includes introducing the Titan
story to Wall Street."
John Hargrove, Chief Executive Officer of Titan, said, "We
believe Bertner Advisors will enable us to extend our investor
reach and to build awareness on Wall Street. The Firm is a perfect
fit for Titan as we continue to move closer to commercialization of
the SPORT™ Surgical System and will enhance a great team, a great
technology and a tremendous opportunity."
The agreement for the engagement of Bertner Advisors will
commence on July 7, 2014 for a term of 36 months. Bertner Advisors
will be paid fees of US$20,000 per month for its services, with an
annual increase of 5% on such monthly fee. An additional fee of six
times the monthly fee shall be paid to Bertner Advisors in the
event that a merger, acquisition, consolidation, or other
transaction occurs, pursuant to which all or substantially all of
the stock, assets, or other interests in Titan are sold or
otherwise conveyed, and such transaction results in a new person or
entity obtaining a fifty percent (50%) or greater ownership
interest in or control over Titan.
The Company's current investor relations and financial
communications services contract with Brooks Communications will
end effective on June 30, 2014. Titan would like to take the
opportunity to thank Beverly Brooks for her services to the
Company.
About Bertner Advisors, LLC
Founded by Sherry Bertner, Bertner Advisors, LLC is a financial
communications consulting firm providing strategic investor
relations services to health care companies. For more information,
visit http://bertneradvisors.com/.
About Titan Medical Inc.
Titan Medical Inc. is a Canadian public company focused on the
design and development of a robotic surgical system for application
in minimally invasive surgery ("MIS"). The Company's Single Port
Orifice Robotic Technology, SPORT™ Surgical System, currently under
development, comprises a surgeon-controlled robotic platform that
includes a 3D vision system and interactive instruments for
performing MIS procedures, and a surgeon workstation that provides
the surgeon with an interface to the robotic platform for
controlling the interactive instruments and providing a 3D
endoscopic view of inside a patient's body during MIS procedures.
The SPORT™ Surgical System is being designed to expand robotic
surgery into areas of surgical specialties and simple and complex
procedures that are currently under-serviced, and to allow surgeons
to perform procedures within small to medium size surgical spaces
such as general surgery and cholecystectomy. For more information,
visit the Company's website at www.titanmedicalinc.com.
Forward-Looking Statements
This news release contains "forward-looking statements" which
reflect the current expectations of management of the Company's
future growth, results of operations, performance and business
prospects and opportunities. Wherever possible, words such as
"may", "would", "could", "will", "anticipate", "believe", "plan",
"expect", "intend", "estimate", "potential for" and similar
expressions have been used to identify these forward-looking
statements. These statements reflect management's current beliefs
with respect to future events and are based on information
currently available to management. Forward-looking statements
involve significant risks, uncertainties and assumptions. Many
factors could cause the Company's actual results, performance or
achievements to be materially different from any future results,
performance or achievements that may be expressed or implied by
such forward-looking statements, including, without limitation,
those listed in the "Risk Factors " section of the Company's Annual
Information Form dated April 4, 2014 (which may be viewed at
www.sedar.com). Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward looking
statements prove incorrect, actual results, performance or
achievements may vary materially from those expressed or implied by
the forward-looking statements contained in this news release.
These factors should be considered carefully and prospective
investors should not place undue reliance on the forward-looking
statements. Although the forward-looking statements contained in
the news release are based upon what management currently believes
to be reasonable assumptions, the Company cannot assure prospective
investors that actual results, performance or achievements will be
consistent with these forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
Titan Medical Inc.John HargroveChairman and Chief Executive
Officer(416) 548-7522 (ext.
151)john.hargrove@titanmedicalinc.comwww.titanmedicalinc.com
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Apr 2023 to Apr 2024